SECISBP2L and B-cell chronic lymphocytic leukemia: There was also a positive correlation between the percentage of intermediate monocytes (CD14+CD16+SLAN−) and the percentage of CD5+CD19+ CLL cells (r = 0.318; p < 0.05).